Synthetic oligonucleotides as modulators of inflammation
about
Heat shock protein bystander antigens for peptide immunotherapy in autoimmune diseaseTreatment of allergic asthma: modulation of Th2 cells and their responsesTiming is critical for an effective anti-metastatic immunotherapy: the decisive role of IFNγ/STAT1-mediated activation of autophagyPainful pathways induced by TLR stimulation of dorsal root ganglion neuronsA guanidine-rich regulatory oligodeoxynucleotide improves type-2 diabetes in obese mice by blocking T-cell differentiation.The origin and properties of extracellular DNA: from PAMP to DAMP.Mannose receptor 1 mediates cellular uptake and endosomal delivery of CpG-motif containing oligodeoxynucleotidesEpigenetics and dermatological disease.Systematic identification of small molecule adjuvants.A specific oligodeoxynucleotide promotes the differentiation of osteoblasts via ERK and p38 MAPK pathways.TLR9-based immunotherapy for the treatment of allergic diseases.Oligodeoxynucleotides inhibit Toll-like receptor 3 mediated cytotoxicity and CXCL8 release in keratinocytes.In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses.T cell-dependent antigen adjuvanted with DOTAP-CpG-B but not DOTAP-CpG-A induces robust germinal center responses and high affinity antibodies in mice.B Cells Produce Type 1 IFNs in Response to the TLR9 Agonist CpG-A Conjugated to Cationic Lipids.Endotracheal tube-induced sore throat pain and inflammation is coupled to the release of mitochondrial DNASynthetic CpG oligonucleotides induce a genetic profile ameliorating murine myocardial I/R injury.
P2860
Q27008837-B31BFB31-25AC-414D-80C1-3A1B89BA87EDQ27011823-B11D61FF-9565-41F0-98C0-771753D97CB0Q34023964-5D9E4849-0E9A-4507-88F0-03BE4E5CB4D5Q34995441-C2370A56-6837-45AC-B4A1-96911920A0CDQ36379556-F582C889-8925-48DB-8727-C468593152F0Q37047827-F1BE94BE-EA8F-4DB9-8CCD-FE8F5600600AQ37325559-C76B605E-D96F-4AA3-B42F-A1DAFB541D70Q37346201-66895D45-3034-4EC3-9272-9F6929705B29Q38020881-04A2B433-E200-43E8-BB55-58D0568535DAQ38322094-0F0690BF-E8AD-4C8B-98F9-CDD6BD0BB896Q39000290-8BD48289-EFE0-465C-A7E1-14C3C237CDAEQ39443382-BB6210C1-4B3B-4DB9-A1F0-FF006D7EB039Q39800142-83BDAC9A-3AA8-4B11-B020-F1A61544A04CQ40111632-E8469F87-361E-4283-BF96-2197E4959A76Q40157161-F0318E9A-DAE8-48C9-ABB0-836FB15B734FQ41079090-84C059C0-ABF0-40CB-9228-2CAA3CDC1DA8Q55366238-991B8712-46DF-4177-8E4D-25BADB52D846
P2860
Synthetic oligonucleotides as modulators of inflammation
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Synthetic oligonucleotides as modulators of inflammation
@en
type
label
Synthetic oligonucleotides as modulators of inflammation
@en
prefLabel
Synthetic oligonucleotides as modulators of inflammation
@en
P2093
P2860
P356
P1476
Synthetic oligonucleotides as modulators of inflammation
@en
P2093
Debra Tross
Dennis Klinman
Hidekazu Shirota
Sven Klaschik
P2860
P304
P356
10.1189/JLB.1107775
P50
P577
2008-04-22T00:00:00Z